Program Updated February 09, 2026
Presidential Session
Presidential Session 1
Hematology Oncology
March 26(Thu.) 8:30 ～ 10:30
Room 1(G3＋G4, 1F, Pacifico Yokohama North)
- Session Information
-
Chair Wataru Munakata Department of Hematology, National Cancer Center Japan Hospital Chair Noriko Fukuhara Department of Hematology, Tohoku University Graduate School of Medicine Discussant Yosuke Minami National Cancer Center Hospital East MOSUNETUZUMAB PLUS POLATUZUMAB VEDOTIN IS SUPERIOR TO R-GEMOX IN PATIENTS WITH R/R LBCL: THE PHASE III SUNMO TRIAL
Speaker Jason Westin MD Anderson Cancer Center EFFICACY OF RITUXIMAB-BENDAMUSTINE +/- ACALABRUTINIB IN PATIENTS WITH MANTLE CELL LYMPHOMA: THE PHASE 3 ECHO TRIAL
Speaker Michael Wang The University of Texas MD Anderson Cancer Center Epcoritamab + rituximab/lenalidomide (R2) vs R2 for relapsed or refractory follicular lymphoma: Results from EPCORE FL-1
Speaker Dai Maruyama Cancer Institute Hospital, Japanese Foundation for Cancer Research Improved long-term tolerability with asciminib (ASC) vs IS-TKIs in newly diagnosed CML-CP: ASC4FIRST week 96 analysis
Speaker Jorge E. Cortes Georgia Cancer Center at Augusta University
Presidential Session 2
Gastorointestinal/Hepatic Oncology
March 26(Thu.) 14:00 ～ 16:00
Room 1(G3＋G4, 1F, Pacifico Yokohama North)
- Session Information
-
Chair Li-Tzong Chen Kaohsiung Medical University Chair Masafumi Ikeda National Cancer Center Hospital East Discussant Hideaki Bando National Cancer Center Hospital East Durvalumab plus FLOT in resectable gastric/gastroesophageal junction cancer in Japan: subgroup analysis of MATTERHORN
Speaker Kei Muro Department of Clinical Oncology, Aichi Cancer Center Hospital SKYSCRAPER-07: Japanese subgroup analyses of a Ph 3 study of atezolizumab ± tiragolumab in unresectable ESCC after dCRT
Speaker Keisho Chin The Cancer Institute Hospital of Japanese Foundation for Cancer Research Precemtabart tocentecan (Precem-TcT, M9140): Results from PROCEADE-CRC-01 and post-hoc analysis in Japanese patients
Speaker Ken Kato National Cancer Center Hospital TALENTACE:A phase III study of TACE combined with atezolizumab + bevacizumab in patients with hepatocellular carcinoma
Speaker Masatoshi Kudo Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine
Presidential Session 3
Thoracic Oncology
March 27(Fri.) 9:50 ～ 11:50
Room 1(G3＋G4, 1F, Pacifico Yokohama North)
- Session Information
-
Chair Takehito Shukuya Juntendo University Chair Tatsuya Yoshida Department of Thoracic Oncology/Experimental Therapeutics, National Cancer Center Hospital Discussant Isamu Okamoto Department of Respiratory Medicine, Graduate School of Medical Sciences, Kyushu University Overall survival with first-line osimertinib ± platinum-pemetrexed for EGFR-mutated advanced NSCLC: FLAURA2 Japan Cohort
Speaker Noriko Yanagitani Department of Thoracic Medical Oncology, The Cancer Institute Hospital, Japanese Foundation for Cancer Research Overall Survival for Amivantamab Plus Lazertinib vs Osimertinib in Asian Participants With 1L EGFR-mutant Advanced NSCLC
Speaker Hidetoshi Hayashi Department of Medical Oncology, Kindai University Faculty of Medicine Subcutaneous vs Intravenous Amivantamab with Lazertinib in EGFR-mutated advanced NSCLC: PALOMA-3 Japanese subset
Speaker Motohiro Tamiya Osaka International Cancer Ifinatamab deruxtecan (I-DXd) in extensive-stage small cell lung cancer: Japanese subgroup analysis from IDeate-Lung01
Speaker Hidetoshi Hayashi Department of Medical Oncology, Kindai University Faculty of Medicine
Presidential Session 4
Breast Cancer
March 28(Sat.) 8:20 ～ 10:20
Room 1(G3＋G4, 1F, Pacifico Yokohama North)
- Session Information
-
Chair Norikazu Masuda Department of Breast Surgery, Graduate School of Medicine, Kyoto University Chair Fumikata Hara Aichi Cancer Center Discussant Junji Tsurutani Showa Medical University, Advanced Cancer Translational Research Institute First-line camizestrant for emergent ESR1 mutations in advanced breast cancer: Japanese subgroup analysis from SERENA-6
Speaker Hiroji Iwata Nagoya City University Pooled safety analysis of sacituzumab govitecan in metastatic breast cancer (mBC), including patients in NA/EU and Asia
Speaker Hope S. Rugo University of California San Francisco Helen Diller Family Comprehensive Cancer Center Sacituzumab govitecan + pembrolizumab vs chemo + pembrolizumab in untreated PD-L1+ advanced TNBC: ASCENT-04/KEYNOTE-D19
Speaker Junichiro Watanabe Juntendo University Graduate School of Medicine, Tokyo, Japan T-DXd vs T-DM1 in high-risk HER2+ primary breast cancer with residual invasive disease after neoadjuvant therapy
Speaker Naoki Niikura Department of Breast Oncology, Tokai University School of Medicine
Presidential Session 5
Translational Research/Phase I
March 28(Sat.) 10:30 ～ 12:00
Room 1(G3＋G4, 1F, Pacifico Yokohama North)
- Session Information
-
Chair Hiroji Iwata Nagoya City University Graduate School of Medical Sciences Chair Nobumasa Mizuno Aichi Cancer Center Hospital Discussant Yasutoshi Kuboki Department of Experimental Therapeutics, National Cancer Center Hospital East MRD Detection by WGS-Based Personalized ctDNA Panels: Breast Cancer Cohort within the MONSTAR-SCREEN-3 Project (ENCORE)
Speaker Meiko Nishimura Department of Breast Medical Oncology, The Cancer Institute Hospital of Japanese Foundation for Cancer Research Efficacy of tyrosine kinase inhibitors by targeted gene mRNA Expression in solid tumors: SCRUM-Japan MONSTAR-SCREEN-2
Speaker Takao Fujisawa National Cancer Center Hospital East DAREON®-7: phase I study of obrixtamig plus chemotherapy in patients with DLL3-positive neuroendocrine carcinomas
Speaker Saori Mishima Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East
Presidential Symposium
Presidential Symposium 1
Asian Oncology- Genitourinary cancer
March 26(Thu.)10:30 ～ 11:50
Room 1（G3＋G4, 1F, Pacifico Yokohama North）
- Session Information
-
Chair Yuji Miura The Cancer Institute Hospital of JFCR Chair Eiji Kikuchi St. Marianna University School of Medicine Speaker Thomas Powles Bart’s Cancer Institute, Queen Mary University of London Speaker Hiroshi Kitamura Department of Urology, Faculty of Medicine, University of Toyama Speaker Shingo Hatakeyama Hirosaki University Graduate School of Medicine, Dept. of Urology Speaker Taigo Kato The University of Osaka Speaker Ravindran Kanesvaran National Cancer Centre Singapore
Presidential Symposium 2
Asian Oncology – Lung cancer
March 26(Thu.)08:30 ～ 10:30
Room 2（G1, 1F, Pacifico Yokohama North）
- Session Information
-
Chair Yasushi Goto National Cancer Center Hospital Chair Tony Mok Department of Clinical Oncology Chinese University of Hong Kong Speaker Hidetoshi Hayashi Department of Medical Oncology, Kindai Univeristy Speaker James Chih-Hsin Yang National Taiwan University Cancer Center Hospital Speaker Byoung Chul Cho Yonsei University Speaker Lu Shun Shanghai Chest Hospital Speaker Tony Mok Department of Clinical Oncology Chinese University of Hong Kong Speaker Yasushi Goto National Cancer Center Hospital
Presidential Symposium 3
Next generation early phase 1 drug development from Asia -That’s defining moment-
March 26(Thu.)14:00 ～ 16:00
Room 2（G1, 1F, Pacifico Yokohama North）
- Session Information
-
Chair Toshio Shimizu Department of New Experimental Therapeutics and Early Phase 1 Drug Development Service, Kansai Medical University Hospital Chair Tira J. Tan National Cancer Center Singapore Speaker Yuki Katsuya Department of Experimental Therapeutics, National Cancer Center Hospital Speaker Toshio Shimizu Department of New Experimental Therapeutics and Early Phase 1 Drug Development Service, Kansai Medical University Hospital Speaker Tira J. Tan National Cancer Center Singapore Speaker Aya El Helali Department of Clinical Oncology, The University of Hong Kong, SAR, China Speaker Pei Jye Voon Universiti Malaysia Sarawak, Malaysia Speaker Toshihiko Doi National Cancer Center Hospital East
Presidential Symposium 4
Comprehensive discussion for strategy, design, investiment, profit and goal for drug develoment in orphan disease
March 26(Thu.)16:05 ～ 17:35
Room 8（G303＋G304, 3F, Pacifico Yokohama North）
- Session Information
-
Chair Kan Yonemori National Cancer Center Hospital Chair Tetsunari Kihira Pharmaceutical Evaluation Division, Pharmaceutical Safety Bureau, MHLW Speaker Takashi Seto NHO Kyushu Cancer Center Speaker Takahiro Mizui Chugai Pharmaceutical Co., Ltd. Speaker Momoko Nabeta Pharmaceuticals and Medical Devices Agency Speaker Hiroyuki Hasegawa Mitsubishi UFJ Capital Co., Ltd. Discussant Toyotaka Iguchi Office of New Drug V, Pharmaceuticals and Medical Devices Agency
Presidential Symposium 5
Passing the Medical Oncology Exam ～Finding Your Path to Glory～
March 27(Fri.)08:20 ～ 09:50
Room 2（G1, 1F, Pacifico Yokohama North）
- Session Information
-
Chair Hidetoshi Hayashi Department of Medical Oncology, Kindai University Chair Emi Noguchi Pharmaceuticals and Medical Devices Agency/National Cancer Center Hospital Speaker Kenji Tamura Department of Medical Oncology, Shimane University Hospital Speaker Takashi Kurosaki Department of Medical Oncology, Izumi City General Hospital Speaker Go Makimoto Department of Respiratory Medicine, Okayama University Hospital Speaker Yutaka Fujiwara Development of Thoracic Oncology, Aichi Cancer Center Speaker Kei Kunimasa Osaka International Cancer Institute Speaker Keisuke Miwa Multidisciplinary Treatment Cancer Center, Kurume University Hospital Discussant Yong-il Kim Yodogawa Christian Hospital Discussant Tomomi Kashiwada Department of Medical Oncology, Saga Medical Center Koseikan Discussant Ikuo Sekine Department of Medical Oncology, University of Tsukuba
Presidential Symposium 6
Asian Education: What makes a world leading medical oncologist and institution？
March 27(Fri.)09:50 ～ 11:50
Room 2（G1, 1F, Pacifico Yokohama North）
- Session Information
-
Chair Kenji Tamura Department of Medical Oncology, Shimane University Hospital Chair Fabrice André Gustave Roussy Speaker Kenji Tamura Department of Medical Oncology, Shimane University Hospital Speaker Fabrice André Gustave Roussy Speaker Erica L. Mayer Dana-Farber Cancer Institute Speaker Makiko Ono Department of Medical Oncology, Cancer Institute Hospital of JFCR Speaker Thanachai Sanlung Khon Kaen Univiersity Speaker Yuko Takahashi Okayama University Hospital Speaker Quy Pham Nguyen Kyoto Miniren Chuo Hospital Speaker Hyehyun Jeong Asan medical center
Presidential Symposium 7
Asian Oncology –Breast cancer: Breast cancer clinical development of Asian, by Asian, for Asian-We will make definitive moment
March 27(Fri.)08:20 ～ 10:20
Room 3（G6, 1F, Pacifico Yokohama North）
- Session Information
-
Chair Sung-Bae Kim Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine Chair Kan Yonemori National Cancer Center Hospital Speaker Kan Yonemori National Cancer Center Hospital Speaker Yen-Shen Lu National Taiwan University Hospital Speaker Yoon Sim Yap National Cancer Centre Singapore Speaker Seock-Ah Im Seoul National University Speaker Junji Tsurutani Advanced Cancer Translational Research Institute, Showa Medical University
Presidential Symposium 8
Asian Oncology – Upper GI cancer
March 28(Sat.)08:20 ～ 10:20
Room 2（G1, 1F, Pacifico Yokohama North）
- Session Information
-
Chair Muro Kei Aichi Cancer Center Chair Sun Young Rha Yonsei University College of Medicine Speaker Kei Muro Aichi Cancer Center Speaker Raghav Sundar Yale University School of Medicine and Yale Cancer Center Speaker Sun Young Rha Yonsei University College of Medicine Speaker Changsong Qi Department of Early Drug Development Centre, Peking University Cancer Hospital & Institute Speaker Ming-Huang Chen Taipei Veterans General Hospital Speaker Hisato Kawakami Department of Medical Oncology, Tohoku University School of Medicine
Presidential Symposium 9
What is the medical oncologist that cancer patients need
March 28(Sat.)10:30 ～ 12:00
Room 2（G1, 1F, Pacifico Yokohama North）
- Session Information
-
Chair Shinsuke Amano Japan Federation of Cancer Patient Groups Chair Kenji Tamura Department of Medical Oncology, Shimane University Hospital Speaker Naomi Sakurai CSR Project, General Incorporated Association Speaker Noriyuki Katsumata Department of Medical Oncology, Nippon Medical School Musashikosugi Hospital Speaker Maiko Higuchi Toyama AYA Cancer Patients Association/Toyama University Hospital Nursing Department, Cancer Nursing Specialist Speaker Yano Seiji Department of Respiratory Medicine, Faculty of Medicine Institute of Medical, Pharmaceutical, and Health Sciences, Kanazawa University Speaker Yoko Matsumoto NPO Ehime Cancer Support Orange no kai Speaker Daijiro Harada The House of Councillors (Komeito)
Presidential Symposium 10
<Approval anniversary symposium as new Japanese medical specialty system> Board certification of a medical oncologist-present and future
March 28(Sat.)08:20 ～ 09:50
Room 3（G6, 1F, Pacifico Yokohama North）
- Session Information
-
Chair Kenji Tamura Department of Medical Oncology, Shimane University Hospital Chair Yuichi Ando Nagoya University Hospital Speaker Kenji Tamura Department of Medical Oncology, Shimane University Hospital Speaker Masahiro Fukuoka Kindai University Speaker Yuichiro Ohe Nomura Hospital Speaker Chikashi Ishioka JR Sendai Hospital Speaker Hironobu Minami Division of Medical Oncology/Hematology, Kobe University Hospital Speaker Yuichi Ando Nagoya University Hospital
Symposium
Gastrointestinal Oncology
Symposium 15
Innovative Therapy for Gastrointestinal Cancer
March 27(Fri.)08:20 ～ 09:50
Room 4（G5, 1F, Pacifico Yokohama North）
- Session Information
-
Chair Izuma Nakayama National Cancer Center Hospital East Chair Raghav Sundar Yale University School of Medicine and Yale Cancer Center Standard Care
Speaker Yu Sunakawa St. Marianna University School of Medicine Molecular targeted agents (mAb, ADC, bispecific)
Speaker Raghav Sundar Yale University School of Medicine and Yale Cancer Center CAR-T therapy
Speaker Changsong Qi Department of Early Drug Development Centre, Peking University Cancer Hospital & Institute mRNA vaccine
Speaker Shigehiro Koganemaru National Cancer Center Hospital East
Symposium 16
Exploring the Best Treatment Sequences for Upper GI Cancer
March 27(Fri.)10:20 ～ 11:50
Room 4（G5, 1F, Pacifico Yokohama North）
- Session Information
-
Chair Kei Muro Aichi Cancer Center Chair Daisuke Takahari Gunma University Graduate School of Medicine Best sequence with Zolbetuximab
Speaker Hirokazu Shoji Department of Gastrointestinal Medical Oncology, National Cancer Center Hospital Best sequence with Ramucirumab
Speaker Sun Young Rha Yonsei University College of Medicine Best sequence with immune-checkpoint inhibitors
Speaker Hisato Kawakami Department of Medical Oncology, Tohoku University School of Medicine The Best Sequence in Gastric Cancer Treatment
Speaker Sylvie Lorenzen Technische Universität München
Hepatobiliary and Pancreatic Oncology
Symposium 24
Advanced HCC: Drug Therapy Update
March 28(Sat.)10:30 ～ 12:00
Room 4（G5, 1F, Pacifico Yokohama North）
- Session Information
-
Chair Chigusa Morizane National Cancer Center Hospital Chair Hiroshi Imaoka National Cancer Center Hospital East Keynote Lecture Masafumi Ikeda National Cancer Center Hospital East Keynote Lecture Changhoon Yoo Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine Discussant Masafumi Ikeda National Cancer Center Hospital East Discussant Changhoon Yoo Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine Discussant Etsuro Hatano Kyoto University Discussant Sadahisa Ogasawara Department of Gastroenterology, Graduate School of Medicine, Chiba University
Symposium 1
Current Status and Future Prospects of Biliary Tract Cancer Chemotherapy
March 26(Thu.)16:05 ～ 17:35
Room 2（G6, 1F, Pacifico Yokohama North）
- Session Information
-
Chair Makoto Ueno Kanagawa Cancer Center Chair Tatsuya Ioka Yamaguchi University Hospital Overview
Speaker Robin Kate Kelley Department of Medicine, Division of Hematology/Oncology, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA Combined immunotherapy for biliary tract cancer
Speaker Kenji Ikezawa Kansai Rosai Hospital, Department of Gastroenterology and Hepatology New Developments in Local Therapy for Biliary Tract Cancer
Speaker Naohiro Okano Department of Medical Oncology, Kyorin University Faculty of Medicine Development of Biliary Tract Cancer in Asia
Speaker Yuta Maruki National Cancer Center Hospital Clinical development based on genomic abnormalities in biliary tract cancer
Speaker Yasuyuki Kawamoto National Cancer Center Hospital
Thoracic Oncology
Symposium 14
Advancing Therapies for EGFR-Mutated Lung Cancer: Challenges and Innovations
March 27(Fri.)15:35 ～ 17:05
Room 3（G8, 1F, Pacifico Yokohama North）
- Session Information
-
Chair Makoto Nishio Cancer institute hospital, Japanese foundation for cancer research Chair Tatsuya Yoshida Department of Thoracic Oncology/Experimental Therapeutics, National Cancer Center Hospital Current Treatment Strategies and Challenges for EGFR-Positive Lung Cancer: A Perspective from Japan
Speaker John V. Heymach MD Anderson Cancer Center Current Treatment Strategies and Challenges for EGFR-Positive Lung Cancer: A Perspective from Japan
Speaker Hiroaki Akamatsu Wakayama Medical University The Potential of Amivantamab: Insights with New Data
Speaker Byoung Chul Cho Yonsei University Development of Therapeutics for EGFR Uncommon Mutations, Including Exon 20 Insertions
Speaker Hibiki Udagawa National Cancer Center Hospital east New Therapeutic Approaches and Strategies to Overcome TKI Resistance in EGFR-Positive Lung Cancer
Speaker Yoshihisa Kobayashi National Cancer Center Research Institute
Symposium 28
Treatment Strategies for Achieving Long-Term Survival in Small Cell Lung Cancer
March 28(Sat.)10:30 ～ 12:00
Room 6（G7, 1F, Pacifico Yokohama North）
- Session Information
- In recent years, various drugs have been developed for small cell lung cancer（SCLC), including immune checkpoint inhibitors, T cell engagers, and antibody-drug conjugates（ADC). Through this symposium, we will learn about the best treatment for SCLC and also understand of the latest drug development status and molecular abnormalities, and discuss treatment strategies and future prospects for long-term survival in SCLC .
Chair Satoshi Oizumi NHO Hokkaido Cancer Center Chair Toshiyuki Kozuki Department of Respiratory Medicine and Allergology, Kochi University Treatment advance and further perspectives in LD-SCLC
Speaker Niels Reinmuth Lung Clinic Gauting Treatment advance and further perspectives in 1st line ED-SCLC
Speaker Taichi Miyawaki Juntendo University Hopsital Treatment for recurrent small cell lung cancer and Drug development in SCLC
Speaker Ryo Ko Division of Thoracic Oncology, Shizuoka Cancer Center Treatment strategies and overcome of resistance based on molecular biological characteristics of SCLC
Speaker Shigeki Umemura National Cancer Center Hospital East
Hematology Oncology
Symposium 6
Novel immunocellular therapy for patients with lymphoid malignancies
March 26(Thu.)14:00 ～ 15:50
Room 4（G5, 1F, Pacifico Yokohama North）
- Session Information
-
Chair Kentaro Fukushima The University of Osaka Hospital, Dept of Chemotherapy Chair Nobuhiko Yamauchi Cancer Institute Hospital of JFCR CAR-T therapy in lymphoid malignancies
Speaker Satoshi Yoshihara Department of Respiratory Medicine and Hematology, Hyogo Medical University Treatment and management of immunocellular therapy for lymphoid malignancies
Speaker Shinichi Makita National Cancer Center Hospital Novel immunocellular therapy for patients with lymphoid malignancies
Speaker Alexey V. Danilov City of Hope National Medical Center
Symposium 7
Up-to-date of genomic medicine and therapy in hematologic malignancies
March 26(Thu.)16:05 ～ 18:05
Room 4（G5, 1F, Pacifico Yokohama North）
- Session Information
-
Chair Jorge E. Cortes Georgia Cancer Center Chair Yosuke Minami National Cancer Center Hospital East Novel molecular targeted therapy in leukemia
Speaker Naval G. Daver Leukemia Research Alliance Program, Professor of Medicine Department of Leukemia MD Anderson Cancer Center NGS profile in myeloid maignancies
Speaker Seiichiro Katagiri Department of Hematology, Tokyo Medical University Genomic medicine in malignant lymphoid diseases
Speaker Akihiro Tomita Department of Hematology, Fujita Health University School of Medicine novel NGS profiling with microenvironment for I/O theapy
Speaker Alexander Bagaev BostonGene Corporation
Breast Cancer
Symposium 12
How do we treat breast cancer with brain metastasis?
March 26(Thu.)10:40 ～ 11:40
Room 6（G7, 1F, Pacifico Yokohama North）
- Session Information
- The choice of therapies for pts with brain metastasis is cotroversy. We debate early vs. delayed local therapy for asymptomatic brain metastasis in HER2-low, HER2-positive and TN breast cancer.
Chair Junji Tsurutani Showa Medical University, Advanced Cancer Translational Research Institute Chair Shigehira Saji Department of Medical Oncology, School of Medicine, Fukushima Medical University Early local therapy for brain mets (1)
Speaker(Pro) Yukinori Ozaki Breast Medical Oncology, Breast Oncology Center, Cancer Institute Hospital, Japanese Foundation for Cancer Research Early local therapy for brain mets (2)
Speaker(Pro) Chikako Funasaka National Cancer Center Hospital East Early local therapy for brain mets (3)
Speaker(Pro) Tsutomu Iwasa Department of Medical oncology, Kindai University, Faculty of medicine Delayed local therapy for brain mets (1)
Speaker(Con) Satomi Watanabe Kindai University Faculty of Medicine Delayed local therapy for brain mets (2)
Speaker(Con) Yuko Akaishi Osaka City General Hospital Delayed local therapy for brain mets (3)
Speaker(Con) Makiko Ono Department of Medical Oncology, Cancer Institute Hospital of JFCR Conclusion Yoon Sim Yap National Cancer Centre Singapore
Symposium 13
Novel endocrine therapy and best treatment sequence in HR+HER2-mBC
March 27(Fri.)10:20 ～ 11:50
Room 3（G6, 1F, Pacifico Yokohama North）
- Session Information
- In recent years, the development of novel endocrine or molecularly targeted therapies for HR+HER2-mBC has been active. In particular, many pivotal Phase 3 trial data have been published for oral SERDs, PI3K inhibitors, AKT inhibitors, and CDK4 inhibitors. We are now at the stage of considering which endocrine therapies are best proposed for which subjects and in which sequence. In particular, it is important to consider the optimal endocrine therapy sequence with adverse event management. In this symposium we would like to discuss the optimal sequence based on the latest endocrine therapy + molecular targeted therapy data.Benchmark trials: Serena-4, Serena-6, Triplet in ET
Chair Hiroji Iwata Nagoya City University Graduate School of Medical Sciences Chair Sandra M. Swain Georgetown University Medical Center Acquired resistance of CDK4/6 inhibitor
Speaker Yen-Shen Lu National Taiwan University Hospital Oral SERD (SERENA4, EMERALD, presevERA, EMBER)
Speaker Hitomi Sakai Advanced Cancer Translational Research Institute, Showa Medical University PI3K inhibitor, AKT inhibitor and toxicity management
Speaker Hope S. Rugo Breast Medical Oncology City of Hope Cancer Center Others (PROTAC, CERCA, Lasofoxifene, SERCA) and overcome of resistance
Speaker Sung-Bae Kim Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine
Gynecologic Oncology
Symposium 26
How to implement new emerging treatment strategy in the field of gynecologic cancer into clinical practice
March 28(Sat.)08:20 ～ 09:50
Room 5（G8, 1F, Pacifico Yokohama North）
- Session Information
-
Chair Jae-Weon Kim Seoul National University Hospital Chair Kan Yonemori National Cancer Center Hospital Current satus and future direction of chemotherapy for patients with Cervical cancer
Speaker David Shao-Peng Tan National University Health System Current satus and future direction of chemotherapy for patients with Ovarian cancer
Speaker Jae-Weon Kim Seoul National University Hospital Current satus and future direction of chemotherapy for patients with Endometrial cancer
Speaker Els Van Nieuwenhuysen Gynaecological Oncology, LKI - KU Leuven Cancer Institute, Belgium
Urological Oncology
Symposium 22
Evolution of the HIF-2alfa inhibitor in renal cell carcinoma
March 28(Sat.)10:30 ～ 12:00
Room 3（G6, 1F, Pacifico Yokohama North）
- Session Information
-
Chair Hiroshi Kitamura Department of Urology, Faculty of Medicine, University of Toyama Chair Eric Jonasch UT MD Anderson Cancer Center History of HIF2α inhibitor development and Japanese involvement
Speaker Eijiro Nakamura National Cancer Center Hospital Japan Speaker Kohji Takemura Department of Medical Oncology, Toranomon hospital Toxicity of HIF2α inhibitors
Speaker Chihiro Kondoh Saitama Prefectual Cancer Center Department of Medical Oncology HIF2α inhibitor-based management of VHL Disease-associated tumors
Speaker Eric Jonasch UT MD Anderson Cancer Center
Head and Neck Cancer
Symposium 3
Multidisciplinary tumor board in head and neck cancer
March 26(Thu.)10:10 ～ 11:40
Room 3（G6, 1F, Pacifico Yokohama North）
- Session Information
-
Chair Christophe Le Tourneau Gustave Roussy Chair Yoshitaka Honma Department of Head and Neck, Esophageal Medical Oncology, National Cancer Center Hospital Keynote Lecture Bhumsuk Keam Seoul National University College of Medicine Discussant Sadamoto Zenda Department pf Radiation Oncology, National Cancer Center Hospital East Discussant Tomoko Yamazaki Department Head and Neck Oncology Division, Saitama Medical University International Medical Center Discussant Tomoya Yokota Department of Head and Neck Medical Oncology, Shizuoka Cancer Center Discussant Takenori Ogawa Dept. of Otolaryngology-Head and Neck Surgery, Gifu University Discussant Yosuke Kito Ishikawa Prefectural Central Hospital
Rare Cancer
Symposium 2
We answer questions about diagonosis and therapeutics for carcinoma of unknown primary
March 26(Thu.)08:30 ～ 10:00
Room 3（G6, 1F, Pacifico Yokohama North）
- Session Information
-
Chair Kazuki Sudo National Cancer Center Hospital Dept. of Medical Oncology Chair Masashi Ando Aichi Cancer Center Hospital Diagnostic tests of CUP
Speaker Yozo Sato Department of Diagnostic & Interventional Radiology, Aichi Cancer Center Hospital Pathology of CUP
Speaker Takeshi Inoue Osaka City General Hospital Treatment of CUP
Speaker Kenji Tsuchihashi Kyushu University Hospital Follow up and other issuesfor CUP
Speaker Taro Yamanaka National Cancer Center Hospital
Translational Research/ Clinical Pharmacology
Symposium 10
Latest findings on multifaceted analytical approaches to the tumor microenvironment
March 26(Thu.)14:00 ～ 15:30
Room 5（G8, 1F, Pacifico Yokohama North）
- Session Information
-
Chair Nobuyuki Tanaka Department of Urology, Keio University School of Medicine Chair Shohei Koyama National Cancer Center Research Institute State-of-the-art analysis techniques using spatial transcriptome analysis
Speaker Yutaka Suzuki Graduate School of Frontier Sciences, The University of Tokyo Analysis of tumor environment using organoids
Speaker Hiroyuki Yasuda Keio University, School of Medicine, Division of Pulmonary Medicine Nuclear Oncology and Theranostics
Speaker Nobuyuki Tanaka Department of Urology, Keio University School of Medicine Comprehensive immunogenomic analysis using fresh clinical specimens
Speaker Shohei Koyama National Cancer Center Research Institute
Symposium 18
Extraction of Caner Spatial Information and Development of Foundetion Models
March 27(Fri.)08:20 ～ 09:45
Room 5（G8, 1F, Pacifico Yokohama North）
- Session Information
-
Chair Mamiko Sakata-yanagimoto Department of Hematology, Institute of Medicine, University of Tsukuba Chair Shumpei Ishikawa Univ. of Tokyo / NCC Development of Foundation AI models for Spatial Cancer Tissue Analysis
Speaker Shun-ichiro Kageyama National Cancer Center Hospital Target Discovery by Analysing Cancer Spatial Information
Speaker Youya Nakazawa Astellas, Oncology Research Integration of Histopathology Information and Spatial Genomics
Speaker Shumpei Ishikawa Univ. of Tokyo / NCC Disease Tissue Homeostasis of Hematological Malignancy
Speaker Mamiko Sakata-yanagimoto Department of Hematology, Institute of Medicine, University of Tsukuba
Symposium 29
Optimal Dosage of Anticancer Drugs and Clinical Pharmacology
March 28(Sat.)10:30 ～ 12:00
Room 8（G303＋G304, 3F, Pacifico Yokohama North）
- Session Information
-
Chair Akinobu Hamada National Cancer Center Chair Hidenori Mizugaki NHO Hokkaido Cancer Center Dose Individualisation Of Anticancer Drugs
Speaker Etienne Chatelut Oncopole Claudius-Regaud, University of Toulouse Introduction to Clinical Pharmacology study in Japan
Speaker Shigehiro Yagishita National Cancer Center Pharmaceutical Companies’ Initiatives in Clinical Pharmacology
Speaker Kimio Terao Chugai Pharmaceutical co.,ltd. Translational Research Div. Pharmaceutical Science Dept. Regulatory Perspectives on Clinical Pharmacology
Speaker Jun Sato National Cancer Center Hospital
Clinical Trial Facilitation Program
Symposium 8
Can MRD Serve as a Surrogate Endpoint in Solid Tumors?
March 26(Thu.)08:30 ～ 10:00
Room 5（G8, 1F, Pacifico Yokohama North）
- Session Information
-
Chair Hideaki Bando National Cancer Center Hospital East Chair Shogo Nomura The University of Tokyo Does adopting MRD clearance as a surrogate endpoint lead to shorter and more efficient clinical trials in solid tumors?
Speaker Hideaki Bando National Cancer Center Hospital East Are MRD assessment methods sufficiently standardized for solid tumors?
Speaker Taigo Kato The University of Osaka Can MRD clearance accurately predict long-term outcomes in solid tumors?
Speaker Qian Shi Department of Quantitative health Sciences, Mayo Clinic Does adopting MRD clearance as a surrogate endpoint lead to shorter and more efficient clinical trials in solid tumors?
Speaker Yukinori Ozaki Breast Medical Oncology, Breast Oncology Center, Cancer Institute Hospital, Japanese Foundation for Cancer Research Are MRD assessment methods sufficiently standardized for solid tumors?
Speaker Takahiro Karasaki Department of Thoracic Surgery, The University of Tokyo Hospital
Symposium 9
Optimizing Cancer Trials: Is a Pragmatic or Explanatory Approach More Effective?
March 26(Thu.)10:10 ～ 11:25
Room 5（G8, 1F, Pacifico Yokohama North）
- Session Information
-
Chair Kenichi Nakamura National Cancer Center Hospital Chair Kenta Murotani Department of Medical Laboratory Science, School of Medicine, Kurume University/Biostatistics Center, Kurume University Pragmatic or Explanatory Approach; Overview
Speaker Shogo Nomura The University of Tokyo A Pragmatic Clincal Trial for mCRC; PRABITAS
Speaker Hiroya Taniguchi Aichi Cancer Center Hospital, Department of Clinical Oncology Pragmatic or Explanatory Approach; A Clinician's Perspective
Speaker Atsuo Takashima National Cacncer Center Hospital, Department of Gastrointestinal Medical Oncology When is a Pragmatic Approach Feasible for Drug Approval?
Speaker Hideaki Takahashi National Cancer Center Hospital East
Symposium 11
Reinforcing oncology early phase 1 capabilities and infrastructures for multiple stakeholders
March 26(Thu.)16:05 ～ 17:35
Room 5（G8, 1F, Pacifico Yokohama North）
- Session Information
-
Chair Noboru Yamamoto National Cancer Center Hospital Chair Toshio Shimizu Department of New Experimental Therapeutics and Early Phase 1 Drug Development Service, Kansai Medical University Hospital Speaker Takako Nakajima Kyoto University Graduate School of Medicine Speaker Yasutoshi Kuboki Department of Experimental Therapeutics, National Cancer Center Hospital East Speaker Sakura Iizumi Development TA (Oncology), Medical Development, R&D, Amgen K.K. Speaker Jun Sato National Cancer Center Hospital
Palliative Care/Symptom Management
Symposium 4
How to Utilize Electronic Devices for Patient-Reported Outcomes: Implementation in Clinical Trials and Real-World Clinical Practice
March 26(Thu.)08:30 ～ 10:00
Room 4（G5, 1F, Pacifico Yokohama North）
- Session Information
-
Chair Masakazu Abe Department of Obstetrics and Gynecology, Hamamatsu University School of Medicine Chair Aya Nishizawa Department of Dermato-Oncology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital ePRO/eCOA as a Key Driver
Speaker Takashi Kawaguchi Tokyo University of Pharmacy and Life Sciences Applying Decentralized Clinical Trials in the Supportive and Palliative Care
Speaker Tatsuo Akechi Nagoya City University Graduate School of Medical Sciences Electronic Patient Reported Outcome Diary for Community-wide Monitoring of Adverse Events
Speaker Koichi Ohata Department of Pharmacy, Gifu University Hospital Development of an ePRO for Quality of Life Assessment Using Life Logs Based on Patients' Perspectives
Speaker Ken Yamaguchi Hiroshima University, Graduate School of Biomedical and Health Sciences, Department of Obstetrics and Gynecology Beyond ePRO: The Future of Patient-Centred Healthcare Unlocked by Disease Management via PHR
Speaker Satoko Zenitani Welby, Inc. Sales & Business Creating Dept.
Symposium 5
Reconsidering Seamless Collaboration with Home Health Care Services
March 26(Thu.)10:10 ～ 11:40
Room 4（G5, 1F, Pacifico Yokohama North）
- Session Information
-
Chair Yoshihisa Matsumoto Department of Palliative Therapy, Cancer Institute Hospital of Japanese Foundation for Cancer Research Chair Hatoe Sakamoto National Cancer Center Hospital East Speaker Kazuhiko Shibata Kouseiren Takaoka Hospital Speaker Masaoki Sasaki Kyoundo Hospital, Sasaki Foundation Speaker Shuji Hiramoto Peace Home Care Clinic Speaker Takeshi Sakamoto Akebono Pharmacy Group Speaker Yu Ishitaka Home nursing station chillna
Symposium 25
Cancer Treatment and Exercise Therapy: Latest Evidence and Clinical Practice
March 28(Sat.)14:30 ～ 16:00
Room 4（G5, 1F, Pacifico Yokohama North）
- Session Information
-
Chair Akira Inoue Department of Palliative Medicine, Tohoku University School of Medicine Chair Asao Ogawa National Cancer Center Hospital East Evidence and Future Perspectives of Exercise Therapy in Cancer Treatment
Speaker Noriatsu Tatematsu Department of Integrated Health Sciences, Nagoya University Graduate School of Medicine The Role of Exercise Therapy for CIPN
Speaker Yuko Tanabe Toranomon Hospital Cancer Treatment and Exercise: Latest Insights in Managing Cachexia and Sensitizing Immunotherapy
Speaker Tateaki Naito Shizuoka Cancer Center Cancer Supportive Care Center Towards Improving the Quality of Rehabilitation for Patients with Terminal Cancer: Insights from a Multi-centre RCT Using the Op-reha Guide
Speaker Nanako Nishiyama Osaka Metropolitan University Clinical Practice of Cancer Rehabilitation in Acute-Care Settings: From Prehabilitation to Discharge Planning
Speaker Junichiro Inoue Kobe University Hospital International Clinical Cancer Research Center Cancer rehabilitation at home and home visiting nursing
Speaker Yasuyo Kumagai Nomura visiting nursing station
Multidisciplinary Team Program
Symposium 23
Frontiers in Hazardous Drug Exposure Control: Approaches to Unresolved Challenges
March 28(Sat.)14:30 ～ 16:00
Room 3（G1, 1F, Pacifico Yokohama North）
- Session Information
-
Chair Koji Matsumoto Division of Medical Oncology, Hyogo Cancer Center Chair Junya Sato Shonan University of Medical Science Keynote Lecture Junya Sato Shonan University of Medical Science Panelists Kazuo Kobayashi Department of Pharmacy, Cancer Institute Hospital, Japanese Foundation for Cancer Research Kaori Sugano Japanese Nursing Association Seiichi Osaki Department of Hospital Pharmacy, NHO Kanmon Medical Center Yuji Murakami Radiation oncology, Hiroshima university hospital Mayumi Yamamoto Jichi Medical University Hospital
Symposium 17
Clinical Dilemmas: Decision-making on Chemotherapy and Multidisciplinary Care for Older Adults with Incurable Cancer and Cognitive Impairment
March 27(Fri.)15:35 ～ 17:05
Room 4（G5, 1F, Pacifico Yokohama North）
- Session Information
-
Chair Tetsuhiro Yoshinami The University of Osaka Hospital Chair Kaori Yagasaki Keio University Faculty of Nursing and Medical Care Speaker Shimon Tashiro Graduate School of Arts and Letters, Tohoku University Speaker Yuichi Ando Nagoya University Hospital Speaker Risako Unoki Yokohama Municipal Citizen's Hospital Speaker Asao Ogawa National Cancer Center Hospital East Speaker Takuji Seo Seo Clinic
Symposium 27
Subcutaneous Administration in Cancer Chemotherapy - Learning from the Past for New Insights
March 28(Sat.)10:30 ～ 12:00
Room 5（G8, 1F, Pacifico Yokohama North）
- Session Information
-
Chair Wataru Okamoto Department of Clinical Oncology, Hiroshima University Hospital Chair Kaori Yagasaki Keio University Faculty of Nursing and Medical Care Discussant Tetsuhiro Yoshinami The University of Osaka Hospital Discussant Yoshihiro Yamamoto Komaki City Hospital Discussant Kinomi Yomiya Hiroshima City Hiroshima Citizens Hospital Discussant Chisato Ichikawa National Cancer Center Hospital East Discussant Tatsunori Shimoi National Cancer Center Hospital Department of Medical Oncology
Cross-sectional Program
Symposium 19
To reduce HPV-related cancers and to increase HPV vaccination rates
March 27(Fri.)10:20 ～ 11:50
Room 5（G6, 1F, Pacifico Yokohama North）
- Session Information
-
Chair Tomoko Yamazaki Department Head and Neck Oncology Division, Saitama Medical University International Medical Center Chair Masayuki Sekine Department of Obstetrics and Gynecology, Graduate School of Medical Science, University of the Ryukyus Keynote Lecture Yutaka Ueda Wakayama Medical University Keynote Lecture Sadao Suzuki Nagoya City University Graduate School of Medical Sciences, Department of Public Health Discussant Nobuhiko Oridate Yokohama City University Discussant Hitomi Imamura Ministry of Health, Labour and Welfare Public Health Bureau Department of Infectious Disease Prevention and Control Vaccination Division Discussant Yutaka Ueda Wakayama Medical University Discussant Tomoko Yamazaki Department Head and Neck Oncology Division, Saitama Medical University International Medical Center Discussant Megumi Kurosawa Department of Obstetrics and Gynecology, Niigata University Medical School
Symposium 21
The current state of oligometastasis
March 28(Sat.)14:30 ～ 16:00
Room 2（G1, 1F, Pacifico Yokohama North）
- Session Information
-
Chair Toru Mukohara National Cancer Center Hospital East Chair Katsunori Shinozaki Division of Clinical Oncology Hiroshima Prefectural Hospital Speaker Yoshiro Nakahara Department of Respiratory Medicine, Kitasato University School of Medicine Speaker Toshiyuki Ishiba Department of Breast Surgery, Institute of Science Tokyo Hospital Speaker Motoo Nomura Department of Clinical Oncology, Kyoto University Hospital Speaker Yukinori Kurokawa Department of Gastroenterological Surgery, The University of Osaka Speaker Ikuno Nishibuchi Department of Radiation Oncology, Hiroshima University
Symposium 30
The near future of combined cancer immunotherapy
March 28(Sat.)10:30 ～ 11:50
Room 12（G401＋G402, 4F, Pacifico Yokohama North）
- Session Information
-
Chair Shigehisa Kitano The Cancer Institute Hospital of JFCR Chair Hiromichi Ebi Aichi Cancer Center Speaker Hiroshi Kagamu Saitama Medical University International Medical Center Speaker Toshio Shimizu Department of New Experimental Therapeutics and Early Phase 1 Drug Development Service, Kansai Medical University Hospital Speaker Tatsuya Yoshida Department of Thoracic Oncology/Experimental Therapeutics, National Cancer Center Hospital Speaker Shigehisa Kitano The Cancer Institute Hospital of JFCR
Patient Advocacy/Survivorship
Symposium 20
Let’s talk about communication among patients, the public, and medical professionals in cancer care
March 27(Fri.)15:35 ～ 17:05
Room 5（G8, 1F, Pacifico Yokohama North）
- Session Information
-
Chair Jiichiro Sasaki Division of Clinical Oncology, Department of Comprehensive Medicine, Research and Development Center for New Medical Frontiers, Kitasato University School of Medicine Chair Kiyotaka Watanabe Division of Medical Oncology, Department of Medicine, Faculty of Medicine, Teikyo University Speaker Masako Okamura Division of Survivorship Research, National Cancer Center Institute for Cancer Control Speaker Kei Hirai Graduate School of Human Sciences, Osaka University Speaker Takuhiro Yamaguchi Tohoku University Graduate School of Medicine Speaker Naomi Sakurai CSR Project, General Incorporated Association Speaker Takashi Muramoto SAPPORO BREWERIES LIMITED
Joint Symposium with International Societies
ASCO/JSMO Joint Symposium
Part 1 Recent Advances in Personalized Therapy for Lung and Breast Cancers
March 26(Thu.)14:00 ～ 15:45
Room 3（G6, 1F, Pacifico Yokohama North）
- Session Information
- Session open for presentation of recent advance in personalized medicine for each cancer fields. ASCO speker present recent advance in each canser and Japanese speaker put recent advances in to context for the Japanse/Asia pacific audience .
Chair Robin Zon ASCO Chair Kenji Tamura Department of Medical Oncology, Shimane University Hospital Speaker Cardinale B. Smith MSKCC Speaker Yasushi Goto National Cancer Center Hospital Speaker Erika P. Hamilton Sarah Cannon Research Institute Speaker Fumikata Hara Aichi Cancer Center
ASCO/JSMO Joint Symposium
Part 2 Recent Advances in Personalized Therapy for Gastrointestinal and Genitourinary Cancers
March 26(Thu.)15:55 ～ 17:40
Room 3（G6, 1F, Pacifico Yokohama North）
- Session Information
- Session open for presentation of recent advance in personalized medicine for each cancer fields. ASCO speker present recent advance in each canser and Japanese speaker put recent advances in to context for the Japanse/Asia pacific audience .
Chair Robin Zon ASCO Chair Kenji Tamura Department of Medical Oncology, Shimane University Hospital Speaker Myriam Chalabi Medical Oncologist. Dept. Of Gastrointestinal Oncology, Netherlands Cancer Institute Speaker Hisato Kawakami Department of Medical Oncology, Tohoku University School of Medicine Speaker Hamid Emamekhoo University of Wisconsin Madison Speaker Nobuaki Matsubara National Cancer Center Hospital East
Asia-Pacific Society/JSMO Joint Symposium
Learning from the Experience of the APAC Medical Oncology Community: Challenges in Clinical Development and Health Economics
March 26(Thu.)10:30 ～ 11:40
Room 2（G1, 1F, Pacifico Yokohama North）
- Session Information
-
Chair James Lynam MOGA President, Department of Medical Oncology, Calvary Mater Hospital Newcastle Chair Ichiro Kinoshita Devision of Clinical Cancer Genomics Speaker Chih-Hung Hsu National Taiwan University Speaker Yeon Hee Park Samsung Medical Center Speaker Kazuki Sudo National Cancer Center Hospital Dept. of Medical Oncology Speaker Takashi Fukuda National Institute of Public Health, Center for Outcomes Research and Economic Evaluation for Health
ESMO/JSMO Joint Symposium
Clinical application of ADCs, biomarkers, and patient selection
March 27(Fri.)15:35 ～ 17:10
Room 1（G3＋G4, 1F, Pacifico Yokohama North）
- Session Information
- About what kind of drug should be developed in ADC, PAN TUMOR, guidelines, and toxicity management.
Chair Fabrice André Gustave Roussy Chair Toshio Shimizu Department of New Experimental Therapeutics and Early Phase 1 Drug Development Service, Kansai Medical University Hospital Speaker Takahiro Kogawa Cancer Institute Hospital of JFCR Speaker Fernanda Mosele Institute Gustave Roussy, Villejuif, France Speaker Kazuki Sudo National Cancer Center Hospital Dept. of Medical Oncology Speaker Giuseppe Curigliano University of Milano and European Institute of Oncology
SIOG/JSMO Joint Symposium
Toward Ethical and Sustainable Cancer Care for Older Adults
March 27(Fri.)08:20 ～ 09:50
Room 1（G3＋G4, 1F, Pacifico Yokohama North）
- Session Information
- Ageism refers to prejudice or discrimination based on age. Older adults with cancer are often subjected to unintentional ageism, which can lead to undertreatment or, conversely, overtreatment. To address this issue, the use of geriatric assessment (GA) and other tailored approaches has been recommended. However, in reality, cancer care for older adults requires considerable time, workforce, and cost. Moreover, as the number of older adults with cancer continues to rise, healthcare expenditures are also increasing, raising concerns about the sustainability of current healthcare systems. In this symposium, we aim to explore ethical and sustainable approaches to cancer care for older adults from various perspectives.
Chair Tomonori Mizutani National Cancer Center / Japan Geriatric Oncology Society (JGOS) Chair Hiroshi Yamamoto Department of Respiratory Medicine, Tokyo Metropolitan Institute for Geriatrics and Gerontology Speaker Kah Poh Loh University of Rochester Medical Center Speaker William Dale George Tsai Family Chair of Geriatric Oncology, City of Hope Speaker Hideo Kunito Japanese Red Cross Medical Center
Joint Symposium with Japanese Societies
Japanese Society of Cancer Nursing (JSCN)/Japanese Society of Medical Oncology (JSMO)
Joint Symposium 1
Outpatient Cancer Chemotherapy Nursing in the Reiwa Era: How Many Patients Can One Nurse Appropriately Handle per Day? — Standardization of Outpatient Chemotherapy Nursing —
March 26(Thu.)08:30 ～ 10:30
Room 6（G7, 1F, Pacifico Yokohama North）
- Session Information
-
Chair Yasuo Hamamoto Department of Medical Oncology, Institute of Science Tokyo Chair Ayako Shibata Aichi Cancer Center Nursing Department Chair Kenji Kawada Fujita Medical University, Department of Medical Oncology Speaker Chieko Fujii Faculty of Nursing and Medical Care, Keio University Speaker Erika Ota St. Luke's International University Speaker Keiko Kunie Tokyo Metropolitan University Speaker Chisato Yamada Aichi Cancer Center Speaker Yuko Kamijo College of Nursing, Kanto Gakuin University
Japanese Society for Radiation Oncology (JASTRO)/Japanese Society of Medical Oncology (JSMO)
Joint Symposium 2
Current Status and Future Perspectives of Immunoradiotherapy
March 26(Thu.)14:00 ～ 16:00
Room 6（G7, 1F, Pacifico Yokohama North）
- Session Information
-
Chair Yoshinori Ito Department of Radiation Oncology, Showa Medical University School of Medicine Chair Kayoko Tsujino Department of Radiation Oncology, Hyogo Cancer Center An Introduction to Immunoradiotherapy
Speaker Yuya Yoshimoto Fukushima Medical University Advanced Clinical Research Center Current status and future perspectives of immunoradiotherapy in head and neck squamous cell carcinoma
Speaker Yoshitaka Homma Department of Head and Neck, Esophageal Medical Oncology, National Cancer Center Hospital Current Status and Future Prospects of Immunoradiotherapy in Lung Cancer
Speaker Hideyuki Harada Shizuoka Cancer Center, Radiation and Proton Therapy Center Novel Advances in Radiotherapy and Immunotherapy for Esophageal Cancer: Toward Synergistic Multimodal Treatment
Speaker Motoo Nomura Department of Clinical Oncology, Kyoto University Hospital Current Status and Outlook of Immuno-(Chemo)Radiotherapy in Uterine Cervical Cancer
Speaker Takafumi Toita Radiation Therapy Center, Okinawa Chubu Hospital
Japanese Society for Palliative Medicine (JSPM)/Japanese Society of Medical Oncology (JSMO)
Joint Symposium 3
Latest Evidence in Cancer Palliative Care
March 26(Thu.)16:05 ～ 17:55
Room 6（G7, 1F, Pacifico Yokohama North）
- Session Information
-
Chair Toshimi Takano The Cancer Institute Hospital of JFCR Chair Eriko Satomi Department of Palliative Medicine, National Cancer Center Hospital Speaker Hironori Mawatari Department of Palliative and Supportive Care, Yokohama Minami Kyosai Hospital Speaker Kozue Suzuki Tokyo Metropolitan Cancer and Infectious Disease Center Komagome Hospital Department of Palliative Care Speaker Takaomi Kessoku International university of health and welfare Narita hospital Speaker Tetsuya Ito Department of Palliative Medicine and Advanced Clinical Oncology, Research Hospital, The Institute of Medical Science, the University of Tokyo Speaker Tomofumi Miura Department of Palliative Medicine, National Cancer Center Hospital East Speaker Akiko Abe Department of Palliative Medicine, National Cancer Center Hospital
Japan Society for Fertility Preservation (JSFP)/Japanese Society of Medical Oncology (JSMO)
Joint Symposium 4
Integrating Oncology and Reproductive Medicine: Gonadal Toxicity Induced by Anticancer drugs
March 27(Fri.)08:20 ～ 09:50
Room 6（G7, 1F, Pacifico Yokohama North）
- Session Information
-
Chair Nao Suzuki Department of Obstetrics and Gynecology, St. Marianna University School of Medicine Chair Chikako Shimizu Department of Breast and Medical Oncology, Japan Health Security Institute - National Center for Global Health and Medicine Speaker Naomi Sakurai CSR Project, General Incorporated Association Speaker Ken-ichirou Morishige Osaka General Medical Center, Center for Reproductive Medicine Speaker Yasushi Yumura Yokohama City University, Medical Center Speaker Armin Bastanfard KIZUNA MEDICAL Co., Ltd. Speaker Kohei Amakasu Pharmaceuticals and Medical Devices Agency Speaker Chieko Ishiguro Japan Institute for Health Security, Center for Clinical Sciences, Department of Data Science, Laboratory of Clinical Epidemiology Symposist Toyotaka Iguchi Office of New Drug V, Pharmaceuticals and Medical Devices Agency
Japan Society of Human Genetics (JSHG)/Japanese Society of Medical Oncology (JSMO)
Joint Symposium 5
Updating information on various issues in the field of precision/genetic medicine for cancer
March 27(Fri.)09:50 ～ 11:50
Room 6（G7, 1F, Pacifico Yokohama North）
- Session Information
-
Chair Akira Hirasawa Department of Clinical Genomic Medicine, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University Chair Issei Imoto Aichi Cancer Center Reserach Institute Speaker Motohiro Kato Department of Pediatrics, the University of Tokyo Speaker Takeshi Kuwata National Cancer Center Hospital East Speaker Kouya Shiraishi National Cancer Center Research Institute Speaker Nao Suzuki Department of Obstetrics and Gynecology, St. Marianna University School of Medicine
Japan Society of Clinical Oncology (JSCO)/Japanese Society of Medical Oncology (JSMO)
Joint Symposium 6
Advances in Individualized Perioperative Therapy: Perspectives on Multidisciplinary Collaboration
March 27(Fri.)15:30 ～ 17:30
Room 6（G7, 1F, Pacifico Yokohama North）
- Session Information
-
Chair Akihito Tsuji Department of Clinical Oncology, Kagawa University Faculty of Medicine Chair Norikazu Masuda Department of Breast Surgery, Graduate School of Medicine, Kyoto University Speaker Eiji Oki Dept Advanced Medicine and Innovative Technology, Kyushu University Hospital Speaker Yoshinori Kagawa Department of Gastrointestinal Surgery, Osaka International Cancer Institute Speaker Hiroko Masuda Department of Breast Surgery, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital Speaker Hirotsugu Kenmotsu Shizuoka Cancer Center Speaker Kenichi Harano Department of Medical Oncology, National Cancer Center Hospital East Speaker Kotaro Suzuki Division of Urology, Kobe University Graduate School of Medicine Speaker Satoshi Nara Department of Hepatobiliary and Pancreatic Surgery, National Cancer Center Speaker Kensuke Kumamoto Genome Medical Science and Medical Genetics, Kagawa University
Japanese Circulation Society (JCS)/Japanese Onco-Cardiology Society (JOCS)/Japanese Society of Medical Oncology (JSMO)
Joint Symposium 7
What to Do When Facing Challenges in Onco-Cardiology: Beyond the Guidelines
March 28(Sat.)08:20 ～ 10:20
Room 4（G5, 1F, Pacifico Yokohama North）
- Session Information
-
Chair Mikio Mukai Osaka Center for Cancer and Cardiovascular Disease Prevention Chair Eishi Baba Department of Comprehensive Oncology Speaker Yuji Okura Department of Onco-cardiology, Niigata Cancer Center Hospital Speaker Kazuko Tajiri Department of Cardiology, National Cancer Center Hospital East Speaker Yoichi Naito Department of General Internal Medicine, National Cancer Center Hospital East Speaker Chikako Kiyotani National Center for Child Health and Development, Children's Cancer Center Speaker Rine Nakanishi Division of Cardiovascular Medicine, Department of Internal Medicine Toho University Faculty of Medicine, Toho University Omori Medical Center Speaker Yoshimitsu Yura Department of Cardiology, Nagoya University School of Medicine
Japanese Society of Pediatric Hematology/Oncology (JSPHO)/Japanese Society of Medical Oncology (JSMO)
Joint Symposium 8
Differences in Treatment Approaches and Support Systems Between Pediatric and Adult Oncology for Advanced Sarcomas in AYA Patients: From Initial Therapy to Long-Term Follow-Up
March 28(Sat.)08:20 ～ 10:20
Room 6（G7, 1F, Pacifico Yokohama North）
- Session Information
-
Chair Ako Hosono National Cancer Center Hospital East Department of Pediatric Oncology, Medical Oncology Chair Moeko Hino Department of Pediatrics, School of Medicine, Chiba University Speaker Ako Hosono National Cancer Center Hospital East Department of Pediatric Oncology, Medical Oncology Speaker Moeko Hino Department of Pediatrics, School of Medicine, Chiba University Speaker Yu Ohyama Kameda Medical Center Speaker Natsumi Oda National Cancer Center Hospital East Speaker Shuichi Ozono Department of Pediatrics and Child Health, Kurume University Speaker Mutsumi Katakura Nihon University School of Dentistry Dental Hospital
Japanese Cancer Association (JCA)/Japanese Society of Medical Oncology (JSMO)
Joint Symposium 9
Crosstalk Between Cancer Research and Clinical Practice: The Frontline of Therapeutic Innovation through Collaboration
March 28(Sat.)14:05 ～ 16:35
Room 6（G7, 1F, Pacifico Yokohama North）
- Session Information
-
Chair Shinji Kohsaka National Cancer Center Research Institute Chair Kuniko Sunami National Cancer Center Hospital Speaker Nobuyuki Kakiuchi The Hakubi Center for Advanced Research, Kyoto University Speaker Yutaka Suzuki Graduate School of Frontier Sciences, The University of Tokyo Speaker Shohei Koyama National Cancer Center Research Institute Speaker Tetsuhiro Yoshinami The University of Osaka Hospital Speaker Takafumi Koyama National Cancer Center Hospital Speaker Shigehisa Kitano The Cancer Institute Hospital of JFCR
Educational Lecture
Educational Lecture 1
| Speaker | Tatsuhiro Shibata | The Institute of Medical Science, The University of Tokyo |
|---|
Educational Lecture 2
| Speaker | Kiyoshi Yoshimura | Department of Clinical Immuno Oncology, Showa Medical University |
|---|
Educational Lecture 3
| Speaker | Hiroki Ueda | Sennan Fujii Hospital, Internal Medicine |
|---|
Educational Lecture 4
| Speaker | Hidetoshi Hayashi | Department of Medical Oncology, Kindai University |
|---|
Educational Lecture 5
| Speaker | Shigehisa Kitano | The Cancer Institute Hospital of JFCR |
|---|
Educational Lecture 6
| Speaker | Tateaki Naito | Shizuoka Cancer Center Cancer Supportive Care Center |
|---|
Educational Lecture 7
| Speaker | Keita Uchino | Toranomon Hospital, Department of Medical Oncology |
|---|
Educational Lecture 8
| Speaker | Yukari Tsubata | Department of Respirology, Graduate School of Medicine, Gifu University |
|---|
Educational Lecture 9
| Speaker | Tomohiro Nishi | Kawasaki Municipal Ida Hospital, Medical Oncology |
|---|
Educational Lecture 10
| Speaker | Nobuya Akizuki | Department of Psucho-Oncology/Psychiatry, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital |
|---|
Educational Lecture 11
| Speaker | Takafumi Koyama | National Cancer Center Hospital |
|---|
Educational Lecture 12
| Speaker | Tomohiro Enokida | National Cancer Center Hospital East, Department of Head and Neck Medical Oncology |
|---|
Educational Lecture 13
| Speaker | Satoshi Yuki | Department of Gastroenterology and Hepatology, Hokkaido University Hospital |
|---|
Educational Lecture 14
| Speaker | Atsuo Takashima | National Cacncer Center Hospital, Department of Gastrointestinal Medical Oncology |
|---|
Educational Lecture 15
| Speaker | Kazuomi Ueshima | Kindai University Faculty of Medicine |
|---|
Educational Lecture 16
| Speaker | Tatsuya Ioka | Yamaguchi University Hospital |
|---|
Educational Lecture 17
| Speaker | Kiichiro Ninomiya | Center for Comprehensive Genomic Medicine, Okayama University Hospital |
|---|
Educational Lecture 18
| Speaker | Satoru Miura | Miura Clinic |
|---|
Educational Lecture 19
| Speaker | Fumikata Hara | Aichi Cancer Center |
|---|
Educational Lecture 20
| Speaker | Yoichi Naito | Department of General Internal Medicine, National Cancer Center Hospital East |
|---|
Educational Lecture 21
| Speaker | Tadaaki Nishikawa | The Jikei University School of Medicine |
|---|
Educational Lecture 22
| Speaker | Kenichi Harano | Department of Medical Oncology, National Cancer Center Hospital East |
|---|
Educational Lecture 23
| Speaker | Aiko Maejima | National Cancer Center Hospital |
|---|
Educational Lecture 24
| Speaker | Yu Oyama | Kameda Medical Center |
|---|
Educational Lecture 25
| Speaker | Ikuo Sekine | Department of Medical Oncology, University of Tsukuba |
|---|
Educational Lecture 26
| Speaker | Daisuke Ennishi | Center for Comprehensive Genomic Medicine, Okayama University Hospital |
|---|
Educational Lecture 27
| Speaker | Kimikazu Yakushijin | Kobe University Hospital |
|---|
Educational Lecture 28
| Speaker | Yuichiro Nawa | Division of Hematology, Ehime Prefectural Central Hospital |
|---|
Educational Lecture 29
| Speaker | Katsunori Shinozaki | Division of Clinical Oncology Hiroshima Prefectural Hospital |
|---|
Educational Lecture 30
| Speaker | Aya Nishizawa | Department of Dermato-Oncology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital |
|---|
Educational Lecture 31
| Speaker | Junko Tanizaki | Department of Medical Oncology, Kindai University Faculty of Medicine |
|---|
Educational Lecture 32
| Speaker | Daisuke Tomizawa | National Center for Child Health and Development |
|---|
Educational Lecture 33
| Speaker | Kuniko Sunami | National Cancer Center Hospital |
|---|
Educational Lecture 34
| Speaker | Yukihiko Sonoda | Department of Neurological Surgery, Faculty of Medicine, Yamagata University |
|---|
Educational Lecture 35
| Speaker | Hiroyuki Shibata | Akita University |
|---|
Committee Program
Committee Program 1
Session 1
Smoking cessation promotion session: Air Pollution and Health Impacts Associated with Waterpipe Use
March 26(Thu.)08:30 ～ 10:30
Room 8（G303＋G304, 3F, Pacifico Yokohama North）
- Session Information
-
Chair Makoto Ueno Kanagawa Cancer Center Chair Minoru Fukuda Japanese Red Cross Nagasaki Genbaku Isahaya Hospital Speaker Ying Jiang University of Occupational and Environmental Health, Japan
Session 2
JSMO social media working group: Cancer information, to whom and how should It be delivered?
~Communication connecting multidisciplinary, multi-institutional, and multi-organizational teams~
- Session Information
-
Chair Shigehisa Kitano The Cancer Institute Hospital of JFCR Chair Yuji Uehara Department of experimental therapeutics Speaker Tomoyuki Goto Shiga General Hospital, Department of Medical Oncology Speaker Rin Ogiya CancerX Speaker Takehito Yamamoto Department of Surgery, Kyoto University Speaker Atsushi Fushimi Department of Breast and Endocrine Surgery, The Jikei University School of Medicine
Committee Program 2
Chemotherapy and Other Drug Therapies for Older Patients with Cancer: JSMO-JSCO Clinical Practice Guidelines - 2nd Edition
March 26(Thu.)14:00 ～ 15:30
Room 8（G303＋G304, 3F, Pacifico Yokohama North）
- Session Information
-
Chair Ayumu Matsuoka Division of Survivorship Research, National Cancer Center Institute for Cancer Control Chair Fumio Nagashima Kyorin University Speaker Hirofumi Ohmura Department of Oncology and Social Medicine, Graduate School of Medical Sciences, Kyushu University Speaker Katsuhiro Miura Nihon University School of Medicine Speaker Tsutomu Takahashi Dept. Hematology Shimane University Hospital Speaker Masayuki Ueno Department of Gastroenterology and Hepatology, Kurashiki Central Hospital Speaker Toshio Kubo Okayama University Hospital Speaker Yumiko Koi Department of Breast Oncology, NHO Kyushu Cancer Center Speaker Satoshi Nitta University of Tsukuba Speaker Yasutaka Sukawa Tokyo medical center Speaker Shintaro Narita Akita University Graduate School of Medicine
Committee Program 3
Cross over Oncology : Medical oncologists pave the way for the future of cancer treatment
March 26(Thu.)08:30 ～ 10:00
Room 14（G404, 4F, Pacifico Yokohama North）
- Session Information
-
Chair Teruhisa Azuma Nara Prefecture General Medical Center Chair Haruko Daga Osaka City General Hospital
Committee Program 4
Multidisciplinary Care for Older Adults with Cancer: Real-World Practice and Interactive Discussion
March 27(Fri.)08:20 ～ 09:50
Room 8（G403+304, 3F, Pacifico Yokohama North）
- Session Information
-
Chair Yukari Tsubata Department of Respirology, Graduate School of Medicine, Gifu University Chair Ayumu Matsuoka Division of Survivorship Research, National Cancer Center Institute for Cancer Control Keynote Lecture Yoshiko Kitagawa Department of Nursing, National Hospital Organization Kyushu Cancer Center Keynote Lecture Daisuke Makiura Kobe University Hospital International Clinical Cancer Research Center Rehabilitation Department Keynote Lecture Ayako Doi Department of Medical Oncology, Tonan Hospital Discussant Yasutaka Sakamoto Yokohama City University Hospital Discussant Chisato Nakamura St. Marianna University Hospital Discussant Kitasato University Hospital Discussant Ayako Shimada Department of HBP & GI Surgery, IUHW Narita Hospital
Committee Program 5
Supply issues surrounding standard treatments for rare cancers - Effective, affordable treatments for those who need them, when they need them -
March 27(Fri.)10:20 ～ 11:50
Room 8（G303＋G304, 3F, Pacifico Yokohama North）
- Session Information
-
Chair Hironobu Minami Division of Medical Oncology/Hematology, Kobe University Hospital Chair Hiroyuki Shibata Akita University Speaker Tatsuya Suzuki Department of Hematology, National Cancer Center Hospital Speaker Toshiaki Okamura Nobelpharma Co., Ltd. Regulatory Affairs Division Speaker Seigo Kinuya Dept. of Nuclear Medicine, Kanazawa University Speaker Sumito Nishidate Non Profit Organization GISTERS / Rare Cancers Japan Speaker Daisuke Fujii Office of Pharmaceutical Industry and Venture Support Policy, Policy Planning Division for Pharmaceutical Industry Promotion and Medical Information Management, Health Policy Bureau, Ministry of Health, Labour and Welfare
Committee Program 6
What Makes Clinical Clerkship Engaging? Exploring Effective Ways to Teach Oncology in Clinical Practice
March 27(Fri.)15:35 ～ 17:05
Room 8（G303＋G304, 3F, Pacifico Yokohama North）
- Session Information
-
Chair Yumi Yoshii Nara University Hospital Chair Yu Sunakawa St. Marianna University School of Medicine Speaker Masanori Isobe Gifu Univeristy Discussant Hiroo Imai Tohoku University Graduate School of Medicine Discussant Yuji Miura The Cancer Institute Hospital of JFCR Discussant Keita Uchino Toranomon Hospital, Department of Medical Oncology
Committee Program 7
How Can Oncologists Contribute to Cancer Education? — Specialists, Go to Schools!
March 28(Sat.)08:20 ～ 09:50
Room 8（G303＋G304, 3F, Pacifico Yokohama North）
- Session Information
-
Chair Tomoko Taniyama National Center for Global Health and Medicine Chair Toshimi Takano The Cancer Institute Hospital of JFCR Speaker Toshimi Takano The Cancer Institute Hospital of JFCR Speaker Yuko Suketomo Japan Women’s College of Physical Education Speaker Kenichi Ishii Shinjuku Yamabuki High School Speaker Aya Miyoshi NPO Cancer Support Kagoshim Speaker Tomoko Taniyama National Center for Global Health and Medicine
Committee Program 8
The Present and Future of Medical Oncology: Discussing Career Paths with Medical Students and Residents
March 28(Sat.)08:20 ～ 09:50
Room 9（G314＋G315, 3F, Pacifico Yokohama North）
- Session Information
-
Chair Yosuke Kito Ishikawa Prefectural Central Hospital Chair Shigemasa Takamizawa Kawasaki Municipal Ida Hospital
Advanced Seminar for CRC
March 27(Fri.)14:35 ～ 17:05
Room 14（G404, 4F, Pacifico Yokohama North）
- Session Information
-
Chair Dai Maruyama Cancer Institute Hospital, Japanese Foundation for Cancer Research Chair Naoko So National Cancer Center Hospital Speaker Dai Maruyama Cancer Institute Hospital, Japanese Foundation for Cancer Research Speaker Izumi Miki National Cancer Center Hospital East Speaker Kazuo Hasegawa NPO Lung Cancer Patient's Association ONE STEP Speaker Takako Aoyama Tottori University Hospital Advanced Medicine,Innovation and Clinical Research Center Speaker Makiko Ohmiya The University of Osaka Hospital Speaker Tomonobu Yoshida Japan Society of Clinical Trials and Research/Novartis